Concepedia

Kenneth T. Takeoka

KT

Statistics

Publications

8

Citations

239

H-Index

8

Active since

2016

Affiliations

Novartis (United States)(Current)

Kenneth T. Takeoka is an author at Novartis (United States) specializing in life sciences, microbiology, and antibacterial resistance.

Publications per year

2016–2018

8

Publications

8

Toxic Accumulation of LPS Pathway Intermediates Underlies the Requirement of LpxH for Growth of Acinetobacter baumannii ATCC 19606

Daryl L. Richie, Kenneth T. Takeoka, Jade Bojkovic et al. · PLoS ONE · 2016 · 48 citations · Full text

, , +15

Mode of Action of the Monobactam LYS228 and Mechanisms Decreasing <i>In Vitro</i> Susceptibility in Escherichia coli and Klebsiella pneumoniae

Charles R. Dean, David T. Barkan, Alun Bermingham et al. · Antimicrobial Agents and Chemotherapy · 2018 · 41 citations · Full text

, , +17

Discovery and Optimization of Phosphopantetheine Adenylyltransferase Inhibitors with Gram-Negative Antibacterial Activity

Colin K. Skepper, Robert J. Moreau, B.A. Appleton et al. · Journal of Medicinal Chemistry · 2018 · 33 citations

, , +17

Fragment-Based Drug Discovery of Inhibitors of Phosphopantetheine Adenylyltransferase from Gram-Negative Bacteria

Robert J. Moreau, Colin K. Skepper, B.A. Appleton et al. · Journal of Medicinal Chemistry · 2018 · 30 citations · Full text

, , +17

LpxK Is Essential for Growth of Acinetobacter baumannii ATCC 19606: Relationship to Toxic Accumulation of Lipid A Pathway Intermediates

Jun-Rong Wei, Daryl L. Richie, Mina Mostafavi et al. · mSphere · 2017 · 27 citations · Full text

, , +17

1–5 of 8